2nd meeting on novel adjuvants currently in/close to human clinical testing: World Health Organization—Organization Mondiale de la Santé Fondation Mérieux, Annecy, France, 5–7 June 2000

This publication has 25 references indexed in Scilit:

• Isolation and characterization of rhesus blood dendritic cells using flow cytometry
  Journal of Immunological Methods, 2001
• Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
  Vaccine, 2001
• Immune responses to ISCOM® formulations in animal and primate models
  Vaccine, 2001
• Protection ofAotusMonkeys byPlasmodium falciparumEBA‐175 Region II DNA Prime–Protein Boost Immunization Regimen
  The Journal of Infectious Diseases, 2001
• Potent Induction of Focused Th1‐Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a RecombinantPlasmodium falciparumMalaria Vaccine
  The Journal of Infectious Diseases, 1999
• Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of Vaccines
  Methods, 1999
• A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
  Vaccine, 1999
• Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice
  Vaccine, 1999
• Overview
  Epidemiologic Reviews, 1999
• CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice
  Proceedings of the National Academy of Sciences, 1998